High Cost of New Hepatitis C Drugs Strains Prison Budgets, Locks Many Out of Cure - WSJ
The Catalyst - A PhRMA Blog | Hepatitis C
The Reality of Prescription Drug Spending in Medicaid
2014-2020 Hepatitis C Treatment Estimates | Newsroom | NCHHSTP | CDC
Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan | Scientific Reports
Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study - The Lancet Regional Health – Western Pacific
New Analysis Reveals the Escalating Costs Associated with Untreated Chronic Hepatitis C | Business Wire
Is Zepatier cost low enough to drive down the Hepatitis C treatment prices?
New affordable hepatitis C combination shows 97% cure rate | aidsmap
To End Hepatitis C, Patients Must Come Before Profits - Open Society Foundations
Treating Hepatitis C in a Substance Use Recovery Program: A Limited-Resource Group Model | NEJM Catalyst
Optima | HCV | Applications
Cost Burden of Hepatitis C Virus Treatment in Commercially Insured Patients
Core Concepts - Addressing Structural Barriers to HCV Treatment - Evaluation and Preparation for Hepatitis C Treatment - Hepatitis C Online
Hepatitis C is 'not something you wish on anybody.' Biden has a plan to end it | PBS NewsHour
Hepatitis C virus elimination: laying the foundation for achieving 2030 targets | Nature Reviews Gastroenterology & Hepatology
Gilead Gets U.S. Approval to Sell New Hepatitis C Drug - WSJ
Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant - American Journal of Transplantation
CDC Recommends Increasing Timely Access to Hepatitis C Treatment | SDAHO
Core Concepts - Treatment of HCV in a Correctional Setting - Treatment of Key Populations and Unique Situations - Hepatitis C Online
